Pharmaceutical company Summit Therapeutics is standing out today, surging to $20.45 and marking a 10.6% change. In comparison ...

Fintel reports that on February 28, 2025, Goldman Sachs initiated coverage of Summit Therapeutics (NasdaqGM:SMMT) with a Buy ...

This decline is attributed to weakness in key markets, including the EU, China, and the UK, coupled with planned model ...

Hopes of a trade deal between Britain and the United States, reignited by President Donald Trump's positive comments after ...

Car and commercial vehicle production in the UK fell 17.7% to 78,012 units in January, amid challenging trade conditions and ...

Goldman Sachs analyst Salveen Richter initiated coverage of Summit Therapeutics (SMMT) with a Buy rating and $42 price target a Summit’s lead ...

Goldman Sachs initiated coverage of Summit Therapeutics (SMMT) with a Buy rating and $42 price target Discover the Best Stocks and Maximize ...

Experts warned that the UK will need to introduce more electric vehicle incentives as a result of the car taxes coming in ...

UK car and commercial vehicle production declined by almost 20 per cent in January, according to the latest figures from the Society of Motor Manufacturers and Traders, amid weakness in key markets.

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

We recently compiled a list of the 15 Stocks That Will Go to The Moon According to Analysts. In this article, we are going to ...

THE challenges facing the car industry in its switch to electric were laid bare yesterday with a double dose of bad news.